Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

(E)-N-{3-[1-(8-fluoro-11H-10-OXA-1-AZA-dibenzo [A,D] cyclohepten-5ylidene)-propyl]-phenyl}-methanesulfonamide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis

US Patent 8101761 · Granted Jan 24, 2012

Estimated economic value: $39,152,000

Assignee

Inventors

View full patent text on Google Patents →